The impact of long-term lithium treatment on renal function in an outpatient population

Ulster Medical Journal

Volumn 77, Issue 2, 2008, Pages 102-105

  McCann, Sarah M ^a   Daly, James ^a   Kelly, Christopher B ^a  

^a ROYAL GROUP OF HOSPITALS TRUST   (United Kingdom)

Author keywords

Depression; Lithium; Renal function

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; CARBAMAZEPINE; CREATININE; DIURETIC AGENT; LITHIUM SALT; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; NORADRENALIN UPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; THYROXINE; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROATE SEMISODIUM;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTICLE; BIOCHEMISTRY; BIPOLAR DISORDER; COMPARATIVE STUDY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEMOGRAPHY; DEPRESSION; DRUG USE; FEMALE; HEALTH SURVEY; HUMAN; KIDNEY DISEASE; KIDNEY FUNCTION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; RETROSPECTIVE STUDY; RISK FACTOR; SCHIZOAFFECTIVE PSYCHOSIS; TREATMENT DURATION;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CREATININE; CROSS-SECTIONAL STUDIES; DEPRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY; KIDNEY FAILURE; LITHIUM COMPOUNDS; MALE; MIDDLE AGED; OUTPATIENTS; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; UREA;

EID: 44449132697     PISSN: 00416193     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Goodwin GM; Consensus Group of the British Association for Psychopharmacology. Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology. J Psychopharmacol 2003;17(2):149-173.
2. Souza FG, Goodwin GM. Lithium treatment and prophylaxis in unipolar depression: a meta-analysis. Br J Psychiatry 1991; 158:666-75.
3. Bauer M, Dopfmer S. Lithium augmentation in treatment-resistant depression: meta-analysis of placebo-controlled studies. J Clin Psychopharmacol 1999;19(5):427-34.
4. Markowitz GS, Radhakrishnan J, Kambham N, Valeri AM, Hines WH, D'Agati VD. Lithium nephrotoxicity- a progressive combined glomerular and tubulointerstitial nephropathy. J Am Soc Nephrol 2000; 11(8):1439-48.
5. Boton R, Gaviria M, Batlle DC. Prevalence, pathogenesis, and treatment of renal dysfunction associated with chronic lithium therapy. Am J Kidney Dis 1987;10(5):329-45.
6. Schou M. Effects of long-term lithium treatment on kidney function: an overview. J Psychiatr Res 1988;22(4):287-90.
7. Walker RG. Lithium nephrotoxicity. Kidney Int Suppl 1993; 44:S93-8.
8. Gitlin MJ. Lithium-induced renal insufficiency. J Clin Psychopharmacol 1993;13(4):276-79
9. von Knorring L, Wahlin A, Nystroem K, Bobman SO. Uraemia induced by long-term renal treatment. Lithium 1990;1:251-3.
10. Kelly CB, Cooper SJ. Toxicelevation of serum lithium concentration by non-steroidal anti-inflammatory drugs. Ulster Med J 1991; 60(2):240-2.
11. Juurlink DN, Mamdani MM, Kopp A, Rochon PA, Shulman KI, Redelmeier DA. Drug-induced lithium toxicity in the elderly: a population-based study. J Am Geriatr Soc 2004;52(5):794-8.
12. NICE Clinical Guideline Number 38. Bipolar disorder: the management of bipolar disorder in adults, children and adolescents in primary and secondary care. National Institute for Health and Clinical Excellence, 2006. Available from: http://www.nice.org.uk/ nicemedia./pdf/CG38fullguideline.pdf. Last accessed February 2008.
13. Bassilios N, Martel P, Godard V, Froissart M, Grünfeld J, Stengel B. Monitoring of glomerular filtration rate in lithium-treated outpatients - an ambulatory laboratory database surveillance. Nephrol Dial Transplant 2008;23(2):562-5. Epub 2007 Nov 13.
14. Johnston AM, Eagles JM. Lithium-associated clinical hypothyroidism. Br J Psychiatry 1999;175:336-9.
15. Lepkifker E, Sverdlik A, Iancu I, Ziv R, Segev S, Kotler M. Renal insufficiency in long-term lithium treatment. J Clin Psychiatry 2004;65(6):850-6.
16. Fahy S, Lawlor BA. Lithium use in octogenarians. Int J Geriatr Psychiatry 2001;16(10):1000-3.
17. Roose SP, Bone S, Haidorfer C, Dunner DL, Fieve RR. Lithium treatment in older patients. Am J Psychiatry 1979;136(6):843-4.
18. Baldessarini RJ, Tondo L, Hennen J. Treating the suicidal patient with bipolar disorder: reducing suicide risk with lithium. Ann N Y Acad Sci 2001;932:24-38.
19. Shulman KI, Rochon P, Sykora K, Anderson G, Mamdani M, Bronskill S, Tran CT. Changing prescription patterns for lithium and valproic acid in old age: shifting practice with-out evidence. BMJ 2003; 326(7396):960-1